Here's What Key Metrics Tell Us About Allstate (ALL) Q1 Earnings

Zacks
05-01

Allstate (ALL) reported $16.8 billion in revenue for the quarter ended March 2025, representing a year-over-year increase of 8.9%. EPS of $3.53 for the same period compares to $5.13 a year ago.

The reported revenue compares to the Zacks Consensus Estimate of $17.13 billion, representing a surprise of -1.91%. The company delivered an EPS surprise of +56.19%, with the consensus EPS estimate being $2.26.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

Here is how Allstate performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

  • Combined Ratio - Property-liability: 97.4% compared to the 98% average estimate based on eight analysts.
  • Expense Ratio - Property-liability: 21.4% versus the seven-analyst average estimate of 22.5%.
  • Loss Ratio - Property-liability: 76% versus the seven-analyst average estimate of 75.2%.
  • Loss Ratio - Auto: 69.3% compared to the 71.5% average estimate based on six analysts.
  • Property-Liability- Net Premiums Earned: $14.03 billion versus $14.17 billion estimated by eight analysts on average. Compared to the year-ago quarter, this number represents a +8.7% change.
  • Property-Liability- Other Revenue: $488 million versus the seven-analyst average estimate of $485.47 million. The reported number represents a year-over-year change of +13.5%.
  • Property-Liability- Net Investment Income: $783 million compared to the $741.90 million average estimate based on seven analysts. The reported number represents a change of +11.5% year over year.
  • Allstate Health and Benefits- Net Investment Income: $25 million compared to the $26 million average estimate based on six analysts. The reported number represents a change of +8.7% year over year.
  • Allstate Health and Benefits- Other Revenue: $131 million compared to the $132.46 million average estimate based on six analysts. The reported number represents a change of -2.2% year over year.
  • Allstate Health and Benefits- Accident and health insurance premiums and contract charges: $487 million versus $491.66 million estimated by six analysts on average. Compared to the year-ago quarter, this number represents a +1.9% change.
  • Corporate and Other- Net Investment Income: $22 million versus the six-analyst average estimate of $25.06 million. The reported number represents a year-over-year change of +22.2%.
  • Premiums earned by brand and line of business- Allstate Protection- Homeowners: $3.66 billion compared to the $3.64 billion average estimate based on five analysts. The reported number represents a change of +16% year over year.
View all Key Company Metrics for Allstate here>>>

Shares of Allstate have returned -4.2% over the past month versus the Zacks S&P 500 composite's -0.2% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

The Allstate Corporation (ALL) : Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10